Gujarat Kidney IPO GMP Today

GMP for Gujarat Kidney IPO started at Rs 0 on 15 December 2025 and stood at Rs 0 on 26 December 2025. The sharpest single-day jump was from Rs 0 on 17 Dec 2025 to Rs 10 on 18 Dec 2025. GMP has moved in both directions during the tracked period. That often means sentiment is unsettled and the final listing price is harder to predict.

Based on today's GMP, Gujarat Kidney IPO listing price estimate is Rs 116.00 per share (issue price Rs 114.00 + GMP Rs 2.00).

Actual listing price will be known on 30 December 2025 when the stock lists on NSE/BSE.

GMP near 1.8% is a weak positive signal. Grey market activity is thin and the listing premium may be limited unless subscription picks up.

GMP is unofficial. Listing gain can differ on listing day.

GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Gujarat Kidney IPO is 5.21x. Compare this with the GMP trend to see if demand aligns. The GMP move around 18 Dec 2025 may reflect how the market reacted once the subscription window activity picked up after 22 Dec 2025.

See live figures on the Gujarat Kidney IPO Subscription Status page.

Gujarat Kidney IPO full details (financials, peers, review).

Gujarat Kidney and Super Speciality Limited (GKASSL), incorporated in 2019, is a regional healthcare provider in central Gujarat specializing in renal sciences and multi-speciality tertiary care. The company operates 7 hospitals and 4 pharmacies across Vadodara, Godhra, Bharuch, Borsad, and Anand, with an operational capacity of 340 beds. It focuses on high-end surgical procedures, including kidney transplants and robotic-assisted surgeries. GKASSL follows an asset-light 'roll-up' strategy, expanding rapidly through the acquisition and integration of existing medical facilities in underserved Tier-II and Tier-III markets.